Benitec Biopharma Inc. stock is traded on the Nasdaq Stock Market under the ticker symbol BNTC. Benitec Biopharma Inc. is in the Biotechnology & Medical Research industry.
Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The Company’s platform, DNA-directed RNA interference (ddRNAi), combines ribonucleic acid (RNA) interference with gene therapy to create medicines that facilitate sustained silencing of disease-causing genes following a single administration. The Company is also engaged in developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The Company's BB-301 is an adeno-associated viral vector (AAV)-based gene therapy designed to permanently silence the expression of the disease-causing gene (to slow, or halt, the biological mechanisms underlying disease progression in OPMD) and to simultaneously replace the mutant gene with a wildtype gene (to drive restoration of function in diseased cells).
Stock Ticker Symbol Lookup
Here you can look up another stock ticker symbol.
Stock Ticker Symbol QETA
Here is another stock ticker symbol that we have information about!
Contact | Disclaimer | Copyright | Privacy